Presentation Information
[ESY2-6]Clinical Outcomes of Nivolumab Combined with Docetaxel, Cisplatin, and 5-Fluorouracil（DCF）Therapy for Unresectable Advanced Esophageal Cancer
Takahito Sugase1, Hiroshi Miyata1, Takashi Kanemura1, Norihiro Matsuura1, Shigeto Nakai2, Takaomi Hagi2, Kotaro Yamashita2, Koji Tanaka2, Tomoki Makino2, Tsuyoshi Takahshi2, Yukinori Kurokawa2, Hidetoshi Eguchi2 (1.Department of Gastroenterological Surgery, Osaka International Cancer Institute, 2.Department of Gastroenterological Surgery, The University of Osaka)